Self admission for myocardial infarction. Controlled trial
British Heart Journal
|April 1, 1983
Summary
Patients with recurrent ischemic pain can self-admit to the hospital, reducing admission time. Early admission, bypassing general practitioners, was linked to successful resuscitation in this randomized controlled trial.
Area of Science:
- Cardiology
- Clinical Medicine
- Health Services Research
Background:
- Ischemic pain recurrence requires timely medical intervention.
- Current pathways for managing recurrent ischemic pain may involve delays.
- Optimizing patient access to hospital care is crucial for acute cardiac events.
Purpose of the Study:
- To evaluate the effectiveness of a self-readmission scheme for patients experiencing recurrent ischemic pain.
- To assess the impact of self-readmission on time to hospital admission.
- To determine if self-readmission influences patient outcomes, including resuscitation success.
Main Methods:
- A randomized controlled trial involving 511 men under 65 years.
- Half of the participants were invited to self-readmit to the hospital upon recurrent ischemic pain.
- Follow-up data collected over 1451 man-years.
Main Results:
- The majority of eligible patients utilized the self-readmission scheme.
- No evidence of unnecessary self-admissions was observed.
- Patients using the scheme had significantly reduced time from pain onset to hospital admission.
- All seven successful resuscitations occurred in patients who self-admitted within 2.5 hours, bypassing their general practitioner.
Conclusions:
- A self-readmission strategy for recurrent ischemic pain is feasible and effective in reducing delays to hospital care.
- Prompt hospital admission, facilitated by self-referral, is associated with improved outcomes in critical cardiac events.
- This approach may enhance patient survival rates during acute ischemic episodes.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...


